node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ACP6 | ANKRD34A | ENSP00000463574 | ENSP00000475189 | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | Ankyrin repeat domain 34A. | 0.461 |
ACP6 | FMO5 | ENSP00000463574 | ENSP00000254090 | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.704 |
ACP6 | GPR89B | ENSP00000463574 | ENSP00000358233 | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | G protein-coupled receptor 89B. | 0.726 |
ACP6 | NBPF11 | ENSP00000463574 | ENSP00000477509 | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | 0.704 |
ANKRD34A | ACP6 | ENSP00000475189 | ENSP00000463574 | Ankyrin repeat domain 34A. | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | 0.461 |
ANKRD34A | LIX1L | ENSP00000475189 | ENSP00000474487 | Ankyrin repeat domain 34A. | LIX1-like protein; Limb and CNS expressed 1 like; Belongs to the LIX1 family. | 0.555 |
ANKRD34A | NBPF11 | ENSP00000475189 | ENSP00000477509 | Ankyrin repeat domain 34A. | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | 0.420 |
FMO5 | ACP6 | ENSP00000254090 | ENSP00000463574 | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | 0.704 |
FMO5 | GPR89B | ENSP00000254090 | ENSP00000358233 | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | G protein-coupled receptor 89B. | 0.672 |
FMO5 | NBPF11 | ENSP00000254090 | ENSP00000477509 | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | 0.654 |
GPR89B | ACP6 | ENSP00000358233 | ENSP00000463574 | G protein-coupled receptor 89B. | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | 0.726 |
GPR89B | FMO5 | ENSP00000358233 | ENSP00000254090 | G protein-coupled receptor 89B. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.672 |
GPR89B | NBPF11 | ENSP00000358233 | ENSP00000477509 | G protein-coupled receptor 89B. | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | 0.732 |
LIX1L | ANKRD34A | ENSP00000474487 | ENSP00000475189 | LIX1-like protein; Limb and CNS expressed 1 like; Belongs to the LIX1 family. | Ankyrin repeat domain 34A. | 0.555 |
LIX1L | NBPF11 | ENSP00000474487 | ENSP00000477509 | LIX1-like protein; Limb and CNS expressed 1 like; Belongs to the LIX1 family. | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | 0.445 |
NBPF11 | ACP6 | ENSP00000477509 | ENSP00000463574 | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | Lysophosphatidic acid phosphatase type 6; Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. Belongs to the histidine acid phosphatase family. | 0.704 |
NBPF11 | ANKRD34A | ENSP00000477509 | ENSP00000475189 | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | Ankyrin repeat domain 34A. | 0.420 |
NBPF11 | FMO5 | ENSP00000477509 | ENSP00000254090 | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.654 |
NBPF11 | GPR89B | ENSP00000477509 | ENSP00000358233 | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | G protein-coupled receptor 89B. | 0.732 |
NBPF11 | LIX1L | ENSP00000477509 | ENSP00000474487 | Neuroblastoma breakpoint family member 11; NBPF member 11; Belongs to the NBPF family. | LIX1-like protein; Limb and CNS expressed 1 like; Belongs to the LIX1 family. | 0.445 |